Nanocarriers For Drug Delivery Research Articles

Design Chemical Exchange Saturation Transfer Contrast Agents and Nanocarriers for Imaging Proton Exchange in Vivo.

Chemical exchange saturation transfer magnetic resonance imaging (CEST MRI) enables the imaging of many endogenous and exogenous compounds with exchangeable protons and protons experiencing dipolar coupling by using a label-free approach. This provides an avenue for following interesting molecular events in vivo by detecting the natural protons of molecules, such as the increase in amide protons of proteins in brain tumors and the concentration of drugs reaching the target site. Neither of these detections require metallic or radioactive labels and thus will not perturb the molecular events happening in vivo. Yet, magnetization transfer processes such as chemical exchange and dipolar coupling of protons are sensitive to the local environment. Hence, the use of nanocarriers could enhance the CEST contrast by providing a relatively high local concentration of contrast agents, considering the portion of the protons available for exchange, optimizing the exchange rate, and utilizing molecular interactions. This review provides an overview of these factors to be considered for designing efficient CEST contrast agents (CAs), and the molecular events that can be imaged using CEST MRI during disease progression and treatment, as well as the nanocarriers for drug delivery and distribution for the evaluation of treatments.

Optimizing an Infusion Method of Producing Cosmos Caudatus Encapsulated In Exosomes as A Nanocarrier for Drug Delivery

Objective: This study aimed to propose different encapsulation methods of a medicinal plant extract Cosmos Caudatus (CC), into HSC-2-derived exosomes. Material and Methods: Encapsulation of HSC-2-derived exosomes was achieved via internal and external infusion. The internal infusion was achieved by treating HSC-2 cells with CC extract and isolating the exosomes from its media (M1_ExoCC). The external infusion was performed by dissolving CC extract with HSC-2 purified plain culture media (M2_ExoCC), direct incubation of isolated exosomes suspended in PBS with CC extract (M3_ExoCC), freeze-thaw incubation of purified HSC-2 media containing CC extract (M4_ExoCC), and freeze-thaw incubation of PBS suspended exosome with CC extract (M5_ExoCC).Results: M1_ExoCC and M2_ExoCC were the most advantageous encapsulation methods in terms of yield, stability and solubility.Conclusion: It was determined that the M1_ExoCC and M2_ExoCC methods yielded the most favorable outcomes across all parameters. The cost-effectiveness and simplicity of these methods make them particularly appealing for scaling up production and translating research findings into clinical practice.

Molecularly imprinting polymethacrylamide onto Cu-based metal-organic framework as a pH-sensitive core-shell nanocarrier for potential anti-cancer drug delivery.

Surface molecularly imprinted polymers (MIPs) are an efficient and rapidly advancing approach, increasingly being utilized in drug delivery systems (DDSs). This research involved synthesizing a core-shell structure, consisting of a metal-organic framework (MOF) core and a doxorubicin (DOX) imprinted polymethacrylamide shell, prepared via precipitation polymerization method in green media. The resulting MOF@MIP was utilized as a nanocarrier for DOX delivery, exhibiting high drug loading capacity and pH responsiveness delivery. The materials were characterized using different techniques such as X-ray diffraction (XRD), scanning electron microscopy (SEM), fourier transform infrared (FTIR), transmission electron microscopy (TEM), dynamic light scattering (DLS), thermal gravimetric analysis (TGA), and zeta potential (ZP). In vitro studies on DOX loading and release demonstrated that a higher amount of DOX was released in a sustained manner under tumor tissue conditions (pH 5, 41 °C) compared to normal physiological conditions (pH 7.4, 37 °C). Additionally, cytotoxicity evaluations revealed significant cytotoxic effects of DOX-loaded MOF@MIP on MCF-7 cells (IC50: 2 μg/mL). Based on these findings, the synthesized MOF@MIP shows promise as a potential candidate for the development of anticancer therapeutic delivery platforms.

A Comprehensive Review on Niosomes as a Strategy in Targeted Drug Delivery: Pharmaceutical, and Herbal Cosmetic Applications.

Niosomes are newly developed, self-assembling sac-like transporters that deliver medication at a specific site in a focused manner, increasing availability in the body and prolonging healing effects. Niosome discovery has increased drugs' therapeutic effectiveness while also reducing adverse effects. This article aims to concentrate on the increase in the worldwide utilization of niosomal formulation. This overview presents a thorough perspective of niosomal investigation up until now, encompassing categories and production techniques, their significance in pharmaceutical transportation, and cosmetic use. The thorough literature review revealed that extensive attention has been given to developing nanocarriers for drug delivery as they hold immense endeavor to attain targeted delivery to the affected area simultaneously shielding the adjacent healthy tissue. Many reviews and research papers have been published that demonstrate the interest of scientists in niosomes. Phytoconstituents, which possess antioxidant, antibiotic, anti-inflammatory, wound healing, anti-acne, and skin whitening properties, are also encapsulated into niosome. Their flexibility allows for the incorporation of various therapeutic agents, including small molecules, proteins, and peptides making them adaptable for different types of drugs. Niosomes can be modified with ligands, enhancing their targeting capabilities. A flexible drug delivery mechanism provided by non-ionic vesicles, which are self-assembling vesicular nano-carriers created from hydrating non-ionic surfactant, cholesterol, or amphiphilic compounds along comprehensive applications such as transdermal and brain-targeted delivery.

Ultrasonication outperforms electroporation for extracellular vesicle cargo depletion

Extracellular vesicles (EVs), submicron-sized membranous structures released by cells, serve as vehicles of tissue-specific proteins and nucleic acids, facilitating intercellular communication and playing roles in pathophysiological processes. Leveraging their unique characteristics, EVs have emerged as promising drug delivery nanocarriers. Electroporation (EP) and ultrasonication (US) are among the prevalent techniques used for loading exogenous drugs into EVs owing to their simplicity and efficiency. However, the effectiveness of the two methods in depleting initial EV cargo has been overlooked. But this information is indispensable, as the bioactive residuals of EVs, notably derived from tumor or stem donor cells, may impact downstream therapeutic effects. Bridging this knowledge gap, therefore, can guide the selection of optimal drugs and loading methods tailored to therapeutic objectives. Here, we used high-throughput sequencing to investigate the protein and small RNA cargo of EVs treated with EP and US, respectively. We found that US exhibits higher efficacy in depleting EV cargo compared to EP, while US may also deplete essential endogenous molecules for combination therapy. Neither method demonstrated significant selectivity in cargo depletion, but they might preferentially retain few specific molecules. Additionally, membrane proteins are more prone to loss during US and EP treatments than cytoplasmic proteins.

Nanocarriers for Delivery of Anticancer Drugs: Current Developments, Challenges, and Perspectives

Cancer, the most common condition worldwide, ranks second in terms of the number of human deaths, surpassing cardiovascular diseases. Uncontrolled cell multiplication and resistance to cell death are the traditional features of cancer. The myriad of treatment options include surgery, chemotherapy, radiotherapy, and immunotherapy to treat this disease. Conventional chemotherapy drug delivery suffers from issues such as the risk of damage to benign cells, which can cause toxicity, and a few tumor cells withstand apoptosis, thereby increasing the likelihood of developing tolerance. The side effects of cancer chemotherapy are often more pronounced than its benefits. Regarding drugs used in cancer chemotherapy, their bioavailability and stability in the tumor microenvironment are the most important issues that need immediate addressing. Hence, an effective and reliable drug delivery system through which both rapid and precise targeting of treatment can be achieved is urgently needed. In this work, we discuss the development of various nanobased carriers in the advancement of cancer therapy—their properties, the potential of polymers for drug delivery, and recent advances in formulations. Additionally, we discuss the use of tumor metabolism-rewriting nanomedicines in strengthening antitumor immune responses and mRNA-based nanotherapeutics in inhibiting tumor progression. We also examine several issues, such as nanotoxicological studies, including their distribution, pharmacokinetics, and toxicology. Although significant attention is being given to nanotechnology, equal attention is needed in laboratories that produce nanomedicines so that they can record themselves in clinical trials. Furthermore, these medicines in clinical trials display overwhelming results with reduced side effects, as well as their ability to modify the dose of the drug.

Glycerol‐Based Copolyesters as Polymeric Nanocarriers for Drug Delivery

ABSTRACTEnzymatic polymerization of glycerol‐based polyesters has emerged as a selective and sustainable strategy for the production of degradable, amphiphilic, PEG‐free polymeric materials. In the present work, we exploited the ability to produce copolyester variants of poly(glycerol adipate) (PGA), by adding a second functionalized diol in a one‐pot fashion. The produced glycerol‐based copolyesters, with a variety of amphiphilic balances and chemical functionalities along the backbone, have been screened as nanocarriers for drug delivery. The stability of the produced nanoparticles (NPs) was tested in relevant biological fluids and after freeze‐drying treatment. The new variants outperformed PGA homopolymers in the penetration through a gel‐like barrier as well as in their efficiency to encapsulate a poorly water‐soluble model drug. All the tested polymeric NPs formulations have demonstrated biocompatibility in both in vitro and in vivo experiments, that utilize Caenorhabditis elegans nematodes. Taken together, these preliminary results highlight the importance of introducing new chemistry along polyester backbones while tuning the amphiphilic nature of the final polymers to improve the performance of NP systems.

Breast Cancer Treatment: The Potential of Organic and Inorganic Nanocarriers in Targeted Drug Delivery

Breast cancer (BC) is the most prevalent form of malignancy among women on a global scale, ranking alongside lung cancer. Presently, conventional approaches to cancer treatment include surgical procedures followed by chemotherapy or radiotherapy. Nonetheless, the efficacy of these treatments in battling BC is often compromised due to the adverse effects they inflict on healthy tissues and organs. In recent times, a range of nanoparticles (NPs) has emerged, exhibiting the potential to specifically target malignant cells while sparing normal cells and organs from harm. This has paved the way for the development of nanoparticle-mediated targeted drug delivery systems, holding great promise as a technique for addressing BC. To increase the efficacy of this new method, several nanocarriers including inorganic NPs (such as magnetic NPs, silica NPs, etc.) and organic NPs (e.g., dendrimers, liposomes, micelles, and polymeric NPs) have been used. Herein, we discuss the mechanism of NP-targeted drug delivery and the recent advancement of therapeutic strategies of organic and inorganic nanocarriers for anticancer drug delivery in BC. We also discuss the future prospects and challenges of nanoparticle-based therapies for BC.

Peptide-Based Biomaterials for Combatting Infections and Improving Drug Delivery.

This review explores the potential of peptide-based biomaterials to enhance biomedical applications through self-assembly, biological responsiveness, and selective targeting. Peptides are presented as versatile agents for antimicrobial activity and drug delivery, with recent approaches incorporating antimicrobial peptides into self-assembling systems to improve effectiveness and reduce resistance. The review also covers peptide-based nanocarriers for cancer drug delivery, highlighting their improved stability, targeted delivery, and reduced side effects. The focus of this work is on the bioactive properties of peptides, particularly in infection control and drug delivery, rather than on their structural design or material characteristics. Additionally, it examines the role of peptidomimetics in broadening biomaterial applications and enhancing resistance to enzymatic degradation. Finally, the review discusses the commercial prospects and challenges of translating peptide biomaterials into clinical applications.

Dynamic reorganization of multivesicular bodies and exosome production impacted by sonoporation

Naturally occurring cell-derived extracellular vesicles (EVs) have emerged as attractive nanocarriers for drug delivery. However, production of large quantities of EVs for clinical applications in a scalable manner remains a significant challenge. This study investigated at the single cell level how sonoporation, or membrane poration produced by ultrasound-induced microbubble cavitation, impacts EV production using mouse macrophage RAW 264.7 cells stably expressing CD63-GFP as a model system. Real-time fluorescence videomicroscopy detected rapid changes in CD63-GFP, a tetraspanin family member highly enriched in intraluminal vesicles tagged with GFP, to track changes in multivesicular bodies (MVBs), which are the cellular compartments where exosomes originate within the cells. Our results revealed distinct dynamic changes in CD63-GFP intensity and distribution in RAW 264.7 cells in terms of response time and duration depending on whether the cells were directly or indirectly impacted by sonoporation, suggesting reorganization of MVBs in response to direct and indirect mechanisms resulted from the mechanical impact of ultrasound pulse on the cells. Analysis of the supernatant from sonoporation-treated RAW 264.7 cells expressing CD63-GFP demonstrated a delayed and sustained increase in the production of CD63-GFP-positive EVs. These results show the robust and detailed effect of sonoporation and reveal insights into sonoporation-induced EV release useful for guiding the application of sonoporation to enhance large-scale EV production.

Poloxamer®s anchored with TAT enhance blood–brain barrier penetration of carbamazepine for the treatment of epilepsy: an in vivo study

Carbamazepine is a pharmacological medication commonly prescribed to treat epilepsy. Dose adjustments, poor bioavailability, and prolonged side effects present significant challenges associated with its use. Poloxamer micelles have demonstrated exceptional properties as nanocarriers for drug delivery. This research aimed to develop Poloxamer nanomicelles containing carbamazepine and assess their potential to cross the blood–brain barrier.Poloxamer 407 and P-85 micelles, anchored with TAT as a ligand and containing carbamazepine, were prepared. The morphology, entrapment efficiency, drug release, stability, and toxicity of nanomicelles were examined, along with animal studies conducted to evaluate their anticonvulsant effects. The distribution of carbamazepine-Poloxamer in the brain and plasma was assessed.The results indicated the successful formation of spherical nanomicelles with an average size of less than 100 nm, and carbamazepine was effectively incorporated into the micelles. Formulations composed of mixtures of Poloxamer exhibited a high encapsulation efficiency of approximately 92.1% and remained stable for three months. A sustained release of carbamazepine was observed for up to 72 h. The anticonvulsant effect of carbamazepine-loaded nanomicelles in mice was found to be significantly greater than that of those treated with carbamazepine solution, with the effect increasing by approximately tenfold. Compared to free carbamazepine, the carbamazepine-loaded nanomicelles exhibited a 5.5-fold increase in the brain targeting index, with no toxicity observed in mice treated with these nanomicelles. These findings suggest that Poloxamer micelles represent a promising nanoscale, controlled-release delivery system that is free from toxicity and can enhance the penetration of carbamazepine into the brain while improving its anticonvulsant activity.Graphical

Polymersomes as Next Generation Nanocarriers for Drug Delivery: Recent Advances, Patents, Synthesis and Characterization

Background: Polymersomes (PS), self-assembled nanostructures formed by amphiphilic block copolymers, have garnered significant attention in recent years due to their unique properties and versatile applications in the fields of drug delivery and biomedicine. They are being prepared for a wide range of complex medicinal compounds, including nucleic acids, proteins, and enzymes. Polymersomes have lately been used as vehicles for delivering varied therapeutic substances and regulating ROS (reactive oxygen species). Due to their immunogenic features, polymersomes could play a critical role in enhancing subunit vaccine and drug delivery against COVID-19 infection. Objective: The prime purpose of this manuscript is to furnish an extensive overview of polymersomes, highlighting their recent advances, fabrication methods, characterization techniques, and pharmaceutical applications. Methods: The article has been amassed using several online and offline manuscripts from reputed journals, books, and other resources. Besides this, various user-friendly interfaces, like Pubmed, Google Scholar, etc, have been utilized to gather the latest data about polymersomes. This domain encompasses recent advancements in the realm of innovations about the delivery of drugs through polymeric vesicles. This field involves innovations or developments in nanocarrier systems as they are efficaciously employed to deliver the desired moiety to the targeted site. Results: PS have been discovered to exhibit remarkable promise in addressing various challenges associated with inadequate bioavailability, targeted drug delivery, dosing frequency, and diminished toxic effects. Over the past decade, such nanovesicles have been effectively employed as a complementary approach to address the issues arising from poorly soluble medications. However, this domain still requires further focus on novel breakthroughs. Conclusion: Polymersomes demonstrate unparalleled potential as innovative carriers, exhibiting remarkable versatility and exceptional biocompatibility. This concise review underscores their extraordinary prospects in diverse fields, accentuating their distinctive attributes and opening new avenues for groundbreaking applications.

Reversible Light-Triggered Stretching of Small-Molecule Photochromic Organic Nanoparticles.

Functional organic nanomaterials are nowadays largely spread in the field of nanomedicine. In situ modulation of their morphology is thus expected to considerably impact their interactions with the surroundings. In this context, photoswitchable nanoparticles that are manufactured, amenable to extensive disassembling upon illumination in the visible, and reversible reshaping under UV exposure. Such reversibility turns to be strongly impaired for photochromic nanoparticles in close contact with a substrate. In situ atomic force microscopy investigations at the nanoscale actually reveal progressive disintegration of the organic nanoparticles under successive UV-vis cycles of irradiation, in the absence of intrinsic elastic forces. These results point out the dramatic interactions exerted by surfaces on the cohesion of non-covalently bonded organic nanoparticles. They invite to harness such systems, often used as biomarkers, to also serve as photoactivatable drug delivery nanocarriers.

Safety of Zein Nanoparticles on Human Innate Immunity and Inflammation.

In recent years, natural polymers have attracted great interest for the development of release systems for vaccine formulations and drug delivery. Zein, a hydrophobic proline-rich protein mixture obtained from maize, is one of the most widely used polymers, very promising for applications in tissue engineering and the parenteral delivery of bioactive agents. Still, we have a limited understanding of the interaction between zein particles and the human immune system, in particular innate immunity/inflammation, which is the first line of defense of our body. Assessing the immune safety of nanoparticles is of central importance for ensuring that nano-formulations for medical use do not cause adverse effects on human health. Here, we evaluated the capacity of zein nanoparticles to induce/modulate the innate/inflammatory response, the development of innate memory, and the macrophage polarization by using reliable in vitro systems based on human primary monocytes and monocyte-derived macrophages. We observed that zein nanoparticles do not influence any of these aspects of the innate immune/inflammatory response, suggesting its safety and its potential efficiency as a nanocarrier for drug or antigen delivery.

Synthesis and evaluation of transdermal rosuvastatin-loaded ultradeformable vesicles: Restoring the serum lipid profile in poloxamer 407-caused hyperlipidemia

The present study aimed to design, optimize and characterize rosuvastatin calcium-loaded transfersomes (ROS-TFs) for potential transdermal application and improved the antihyperlipidemic effect of ROS. ROS-TFs were prepared by the lipid thin film hydration method using soy phosphatidylcholine (SPC) to form lipid bilayers and tween 80 (T80) or sodium cholate (SC) as an edge activator (EA). The ROS-TFs were optimized for several parameters, including the proportions of SPC and EA, the particle size (PS) and the entrapment efficiency (EE%). The optimized formulation showed a PS of 169 ± 0.7 nm, zeta potential (ZP) of −19.05 ± 0.4 mV, polydispersity index (PDI) of 0.19 ± 0.02 and EE% of 72.71 ± 1.77. The optimized formulation was further incorporated into a Carbopol 940 gel to obtain a rosuvastatin calcium-loaded transfersomal gel (ROS-TFG) to prolong its residence time on skin. The resulting ROS-TFs exhibited sustained drug release followed by ROS-TFG after 2 h at a pH of 7.4. Skin permeation studies showed enhanced skin permeation of ROS-TFs compared to that of the plain drug gel at a pH of 7.4. In vivo antihyperlipidemic results demonstrated a significant improvement in the lipid profile of the ROS-TFG group in contrast to that of the plain drug gel group. Taken together, these findings indicate that ROS-TFs could be promising nanocarriers for transdermal drug delivery with enhanced antihyperlipidemic effects in the treatment of hyperlipidemia.

Development of Stable and Intensified Mixing Processes for the Precise and Scalable Production of Uniform Drug Delivery Nanocarriers.

Nanocarriers show great promise in drug delivery but face challenges in stability, uniformity, and morphology control. This work introduces an enhanced mixing process to overcome these obstacles, specifically aiming to produce consistently sized poly(lactic-co-glycolic) acid (PLGA) nanoparticles loaded with anti-tumor drugs. By innovatively integrating a pulsation dampener into the microfluidic channels of a continuous flow preparation system, the flow stability of piston pumps is improved nearly tenfold. Consequently, large-scale production of uniformly sized nanoparticles with customizable dimensions is achieved through nanoprecipitation. Furthermore, incorporating terminal double-bond-functionalized poly(lactic-co-glycolic acid)-b-poly(ethylene glycol)-maleimide (PLGA-PEG-Mal) enables these nanoparticles to act as nano-crosslinkers. This facilitates in situ crosslinking with thiolated hyaluronic acid via a spontaneous thiol-ene coupling reaction under physiological conditions, allowing for minimally invasive drug administration and significantly enhancing localized drug retention. The material's degradability in the presence of endogenous enzymes ensures controlled drug release, as demonstrated with the anti-tumor drug doxorubicin (DOX). Validation in a murine breast cancer model shows reduced toxicity and a substantial reduction in tumor weight compared to the free DOX group. These findings confirm the approach's effectiveness for breast cancer treatment and pave the way for innovative solutions in nanomedicine, providing a practical microfluidic mixing system for the design and large-scale production of nanomedicines.

Heparin-functionalized Cu-based metal-organic framework: An efficient active and passive targeting nanocarrier for anticancer doxorubicin drug delivery

In this study, by innovative combining the unique characteristics of Cu-based metal-organic framework (MOF) with the versatile attributes of saccharides (i.e., heparin, Hep), a promising approach is established for active and passive targeting DDS, Cu-MOF/Hep, with a pH-controlled release profile and enhanced drug efficacy. The characterization of the synthesized materials (i.e., FT-IR, XRD, SEM, EDX, TEM, DLS, and TGA) confirms the successful synthesis of Cu-MOF/Hep. In vitro studies concerning the loading and release of DOX observed that a higher amount of DOX was released at pH 5 (>90 % on 96 h, 41 °C) compared to pH 7.4 (<10 % on 96 h, 37 °C). The sensitive feature of the used MOF to the pH conditions increased the drug release in environmental conditions similar to cancer tissues. Furthermore, cytotoxicity assessments indicated notable cytotoxicity effects of DOX-loaded Cu-MOF/Hep on MCF-7 cells (IC50: ∼10 μg/mL in 48 h) with a significant apoptosis rate. The existence of CD44 receptors on the surfaces of cells underscores the significance of Hep-modified systems in facilitating the apoptosis of cancerous cells. The results suggest that the combined Cu-MOF and Hep have the potential to be a viable option for creating platforms that deliver anticancer treatments.

Plasmomagnetic hybrid gold nanostructures as multifunctional nanocarriers for drug delivery, MRI contrast, and photothermal therapy of drug-resistant cancer cells

Presenting a simple efficient method, plasmomagnetic hybrid nanostructures (PNIPAM coated gold nanorods-dexpion hybrid nanostructure, PN-GDHNs) capable of serving as dual drug nanocarriers, MRI contrast, and photothermal agents for cancer therapy were synthesized. The cisplatin (CDDP) and doxorubicin (DOX) were loaded on PN-GDHNs and tested for their drug release, cytotoxicity, photothermal, and MRI contrast in vitro. We found that the drug release was controlled by pH and temperature, and the cytotoxicity was enhanced by the combination of chemotherapy and photothermal therapy. We also found that the PN-GDHNs could overcome the drug resistance of MCF7 breast cancer cells and improve the MRI contrast. We achieved a high cancer cell-killing efficiency of 97.3 ± 0.4 % in one dose with low drug concentration and laser power. Our results suggest that PN-GDHNs are promising multifunctional nanocarriers for cancer therapy applications.

Stable Porous Organic Cage Nanocapsules for pH-Responsive Anticancer Drug Delivery for Precise Tumor Therapy.

The search for drug nanocarriers with stimuli-responsive properties and high payloads for targeted drug delivery and precision medicine is currently a focal point of biomedical research, but this endeavor still encounters various challenges. Herein, a porous organic cage (POC) is applied to paclitaxel (PTX) drug delivery for cancer therapy for the first time. Specifically, water-soluble, stable, and biocompatible POC-based nanocapsules (PTX@POC@RH40) with PTX encapsulation efficiency over 98% can be synthesized by simply grafting nonionic surfactant (Polyoxyl 40 hydrogenated castor oil, RH40) on the POC surface. These PTX@POC@RH40 nanocapsules demonstrate remarkable stability for more than a week without aggregation and exhibit pH-responsive behavior under acidic conditions (pH 5.5) and display sustained release behavior at both pH 7.4 and pH 5.5. Intravenous administration of PTX@POC@RH40 led to a 3.5-fold increase in PTX bioavailability compared with the free PTX group in rats. Moreover, in vivo mouse model experiments involving 4T1 subcutaneous breast cancer tumors revealed that PTX@POC@RH40 exhibited enhanced anticancer efficacy with minimal toxicity compared with free PTX. These findings underscore the potential of POCs as promising nanocarriers for stimuli-responsive drug delivery in therapeutic applications.

Nanomaterials Marvels: Transformative Advancements in Biomedicine, Drug Delivery, and Pharmaceutical Analysis

Nanoparticles are solid colloidal particles ranging in size from 10 to 1000 nm having high surface area-to-volume ratio which allows them for efficient interaction with biological systems. Nanoparticles offer many benefits in comparison to larger particles such as increased surface-to-volume ratio and increased magnetic properties. Nanomaterials hold the potential to revolutionize in critical domains like Biomedicine, Drug Delivery, and Pharmaceutical Analysis. These particles can be functionalized with specific molecules to target diseased cells or tissues, enhancing the efficacy of drugs while minimizing side effects. For instance, gold nanoparticles conjugated with antibodies can be used for targeted cancer therapy, delivering therapeutic agents directly to tumor cells. Similarly drugs encapsulated within nanoparticles can be protected from premature degradation and released in a controlled manner at the target site improving their drug solubility, and enhance cellular uptake, leading to better therapeutic effect in treatment strategies. Polymeric nanoparticles, liposomes, and micelles are some examples of commonly used nanocarriers for drug delivery. Nanomaterials are finding increasing applications in pharmaceutical analysis and can be employed as highly sensitive detection probes for drugs, metabolites, and biomarkers. Additionally, nanomaterials can be used for the separation and purification of bio molecules, facilitating accurate and efficient analysis. This review explores different types of nano materials used exploring their new advances and applications in biomedicine, drug delivery, and pharmaceutical analysis. As research continues to overcome current challenges, nanomaterials unique properties hold immense promise for revolutionizing healthcare and improving patient outcomes.